Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M32.9Revenue (TTM) $M69.6Net Margin (%)70.9Altman Z-Score-4.7
Enterprise Value $M4.7EPS (TTM) $0.6Operating Margin %47.2Piotroski F-Score5
P/E(ttm)0.7Beneish M-Score9.3Pre-tax Margin (%)70.9Higher ROA y-yY
Price/Book1.410-y EBITDA Growth Rate %--Quick Ratio7.9Cash flow > EarningsN
Price/Sales0.55-y EBITDA Growth Rate %--Current Ratio7.9Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)110Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)261Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M71.6ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with THLD

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
THLDCharles Brandes 2016-09-30 Buy $0.47 - $1.29
($0.83)
$ 0.46-45%New holding140,000
THLDFirst Eagle Investment 2016-09-30 Add$0.47 - $1.29
($0.83)
$ 0.46-45%Add 86.75%5,974,802
THLDFirst Eagle Investment 2016-06-30 Buy 0.01%$0.32 - $0.64
($0.43)
$ 0.467%New holding3,199,433
THLDFirst Eagle Investment 2015-12-31 Sold Out -0.01%$0.46 - $4.4
($2.95)
$ 0.46-84%Sold Out0
THLDFirst Eagle Investment 2015-09-30 Reduce-0.01%$3.62 - $5.11
($4.31)
$ 0.46-89%Reduce -60.65%500,000
THLDFirst Eagle Investment 2015-06-30 Reduce$3.49 - $4.51
($4.01)
$ 0.46-89%Reduce -9.60%1,270,768
THLDFirst Eagle Investment 2015-03-31 Add$3.33 - $4.61
($3.99)
$ 0.46-88%Add 2.06%1,405,768
THLDFirst Eagle Investment 2014-12-31 Add$2.7 - $3.56
($3.02)
$ 0.46-85%Add 26.17%1,377,448
THLDFirst Eagle Investment 2014-09-30 Add$3.75 - $5.03
($4.2)
$ 0.46-89%Add 36.46%1,091,700
THLDFirst Eagle Investment 2014-03-31 Add0.01%$4.34 - $5.72
($4.92)
$ 0.46-91%Add 250.00%700,000
THLDFirst Eagle Investment 2012-12-31 Buy $3.98 - $6.55
($4.67)
$ 0.46-90%New holding200,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

THLD is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


THLD: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Fernandes Joel ASenior Vice President 2015-09-28Buy3,562$3.96-88.38view
JAEGER WILFRED EDirector 2015-02-18Buy25,000$3.75-87.73view
Davar NipunVice President 2014-10-13Buy3,000$2.99-84.62view
YOUNGER WILLIAM H JR10% Owner 2014-10-01Sell242,396$3.77-87.8view
WHITE JAMES N10% Owner 2014-10-01Sell239,538$3.77-87.8view
SWEET DAVID E10% Owner 2014-10-01Sell229,154$3.77-87.8view
Speiser Michael L10% Owner 2014-10-01Sell227,228$3.77-87.8view
SHEEHAN ANDREW T10% Owner 2014-10-01Sell230,352$3.77-87.8view
Pullara Samuel J III10% Owner 2014-10-01Sell226,657$3.77-87.8view
GAITHER JAMES C10% Owner 2014-10-01Sell231,287$3.77-87.8view

Press Releases about THLD :

Quarterly/Annual Reports about THLD:

News about THLD:

Articles On GuruFocus.com
Tuesday Pre-Market Insights: THLD, PLL, AOL, CALL May 12 2015 
Threshold Pharmaceuticals Inc. (THLD) CEO Harold E Selick buys 47,619 Shares Mar 15 2011 
Threshold Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 04 2010 
Threshold Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 05 2010 
Threshold Pharmaceuticals Inc. Reports Operating Results (10-Q) May 06 2010 
Threshold Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 05 2009 
Threshold Pharmaceuticals Inc. (THLD) CEO Harold E Selick buys 52,356 Shares Oct 06 2009 
Threshold Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 06 2009 
Threshold Pharmaceuticals Inc. (THLD) CEO Harold E Selick buys 20,000 Shares Jun 05 2009 
Threshold Pharmaceuticals Inc. Reports Operating Results (10-Q) May 07 2009 

More From Other Websites
Threshold Pharmaceuticals Announces Presentation and Webcast at the Stifel Healthcare Conference... Nov 15 2016
THRESHOLD PHARMACEUTICALS INC Financials Nov 15 2016
THRESHOLD PHARMACEUTICALS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a... Nov 15 2016
Merck KGaA expects profit gain from lower development costs Nov 15 2016
Threshold Pharmaceuticals Reports Third Quarter Financial Results Nov 07 2016
Threshold Pharmaceuticals posts 3Q loss Nov 07 2016
Threshold Pharmaceuticals posts 3Q loss Nov 07 2016
Threshold Pharmaceuticals Reports Third Quarter Financial Results Nov 07 2016
THRESHOLD PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Nov 07 2016
Caris Life Sciences and Threshold Pharmaceuticals Collaborate to Utilize Caris' ADAPT Biotargeting... Oct 25 2016
Caris Life Sciences and Threshold Pharmaceuticals Collaborate to Utilize Caris' ADAPT Biotargeting... Oct 25 2016
THRESHOLD PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers Oct 18 2016
Is Threshold Pharmaceuticals a Buy? (THLD) Oct 03 2016
THRESHOLD PHARMACEUTICALS INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change... Sep 30 2016
Why Investors Are Buzzing About Threshold Pharmaceuticals, Enbridge, Facebook and More Sep 30 2016
COO of Threshold Pharmaceuticals to Resign (THLD) Sep 29 2016
Threshold Pharmaceuticals Announces Interim Results from Tarloxotinib Program and its Plans to Focus... Sep 29 2016
Threshold Pharmaceuticals Announces Interim Results from Tarloxotinib Program and its Plans to Focus... Sep 29 2016
THRESHOLD PHARMACEUTICALS INC Files SEC form 8-K, Costs Associated with Exit or Disposal Activities,... Sep 29 2016
Key FDA Decisions and Trial Results Coming in the Next 2 Months Sep 14 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)